Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Faron Pharmaceuticals (FARN) Share Price

Price 210.00p on 15-08-2025 at 05:00:02
Change 0.00p 0%
Buy 0.00p
Sell 0.00p
Last Trade: Sell 294.00 at 207.10p
Day's Volume: 0
Last Close: 210.00p
Open: 0.00p
ISIN: FI4000153309
Day's Range 0.00p - 0.00p
52wk Range: 142.50p - 265.00p
Market Capitalisation: £245.60m
VWAP: 0.00p
Shares in Issue: 116.95m

Faron Pharmaceuticals (FARN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 294 207.10p Ordinary
15:58:15 - 14-Aug-25
Sell* 350 207.10p Ordinary
15:01:04 - 14-Aug-25
Buy* 60 210.50p Ordinary
14:33:44 - 14-Aug-25
Buy* 1,433 211.50p Ordinary
08:45:54 - 14-Aug-25
Buy* 3,500 211.50p Ordinary
10:59:00 - 13-Aug-25
Buy* 2,353 212.00p Ordinary
09:27:24 - 13-Aug-25
Buy* 22 220.00p SI Trade
08:06:35 - 13-Aug-25
Buy* 1 220.00p SI Trade
08:06:35 - 13-Aug-25
Sell* 66 200.00p SI Trade
08:06:35 - 13-Aug-25
Sell* 302 206.60p Ordinary
11:19:15 - 12-Aug-25
See more Faron Pharmaceuticals trades

Faron Pharmaceuticals (FARN) Share Price History

Time period:
to
Date Open High Low Close Volume
14th Aug 2025 (Thu) 210.00 210.00 210.00 210.00 2,137
13th Aug 2025 (Wed) 212.50 212.50 210.00 210.00 5,942
12th Aug 2025 (Tue) 210.00 212.50 210.00 212.50 2,905
11th Aug 2025 (Mon) 210.00 210.00 210.00 210.00 3,252
8th Aug 2025 (Fri) 207.50 210.00 200.00 210.00 31,845
7th Aug 2025 (Thu) 225.00 225.00 207.50 207.50 46,266
6th Aug 2025 (Wed) 195.00 235.00 195.00 225.00 70,315
5th Aug 2025 (Tue) 185.00 195.00 185.00 195.00 6,628
4th Aug 2025 (Mon) 192.50 192.50 185.00 185.00 10,533
1st Aug 2025 (Fri) 192.50 192.50 192.50 192.50 3,865
31st Jul 2025 (Thu) 185.00 192.50 185.00 192.50 14,147
30th Jul 2025 (Wed) 195.00 197.00 197.00 197.00 18,989
29th Jul 2025 (Tue) 187.50 195.00 187.50 195.00 12,055
28th Jul 2025 (Mon) 202.50 202.50 187.50 187.50 16,248
25th Jul 2025 (Fri) 202.50 202.50 202.50 202.50 1,935
24th Jul 2025 (Thu) 197.50 205.00 197.50 202.50 13,291
23rd Jul 2025 (Wed) 200.00 200.00 197.50 197.50 2,987
22nd Jul 2025 (Tue) 205.00 198.00 198.00 198.00 9,708
21st Jul 2025 (Mon) 205.00 205.00 205.00 205.00 3,607
18th Jul 2025 (Fri) 205.00 205.00 202.50 205.00 10,361
17th Jul 2025 (Thu) 207.50 207.50 205.00 205.00 5,884
16th Jul 2025 (Wed) 207.50 207.50 207.50 207.50 306
15th Jul 2025 (Tue) 207.50 207.50 207.50 207.50 1,334
See more Faron Pharmaceuticals price history

Faron Pharmaceuticals (FARN) Regulatory News

Date Source Headline
3rd Mar 2025 12:05 pm RNS FDA Grants Orphan Drug Designation
28th Feb 2025 12:00 pm RNS Notice of Annual General Meeting
27th Feb 2025 7:30 am RNS Positive EMA Opinion on Orphan Drug Designation
27th Feb 2025 7:15 am RNS Annual Report 2024 published
27th Feb 2025 7:00 am RNS Financial Statement 1 January to 31 December 2024
19th Feb 2025 10:00 am RNS Notice of Financial Statement and Annual Report
14th Feb 2025 12:00 pm RNS Holding(s) in Company
11th Feb 2025 7:30 am RNS Change of Broker
6th Feb 2025 3:00 pm RNS Holding(s) in Company
6th Feb 2025 7:00 am RNS Results of Oversubscribed Placing
See more Faron Pharmaceuticals regulatory news

Faron Pharmaceuticals (FARN) Share News

Faron Pharma hails therapy data on blood cancer ahead of FDA meeting

6th Aug 2025 14:32

(Alliance News) - Faron Pharmaceuticals Ltd on Wednesday announced data for its investigational immunotherapy bexmarilimab, ahead of an upcoming meeting with the US Food & Drug Administration. Read More

AIM WINNERS & LOSERS: CT Automotive to post half-year revenue decline

6th Aug 2025 11:01

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Wednesday. Read More

LONDON MARKET OPEN: Europe opens higher ahead of construction PMI data

6th Aug 2025 09:05

(Alliance News) - European blue-chips opened in the green on Wednesday, after US stocks retreated on Tuesday ahead of US President Donald Trump's tariffs becoming effective on Thursday. Read More

IN BRIEF: Faron Pharmaceuticals Chair Tuomo Patsi adds to shareholding

2nd Jul 2025 13:23

Faron Pharmaceuticals Ltd - Turku, Finland-based developer of cancer immunotherapies - Non-Executive Chair Tuomo Patsi buys 21,500 ordinary shares at EUR2.435 per share on Monday for a total of EUR52,353. Brings Patsi's shareholding in Faron to 53,265 shares, with 0.05% of company voting rights. Read More

IN BRIEF: Faron Pharmaceuticals appoints new chief business officer

21st May 2025 12:41

Faron Pharmaceuticals Ltd - Turku, Finland-based developer of cancer immunotherapies - Appoints Ralph Hughes as chief business officer, effective from next Wednesday. Notes Hughes' prior experience as senior vice president at PharmaVentures, and his extensive experience in commercial due diligence, market access and the business development process. Adds that he will be part of the management team and the business development team. "We are delighted to have such an experienced pharmaceutical market access and strategic commercial development expert to join us as the new CBO", says Chief Executive Juho Jalkanen. "Ralph's proven track record in biopharma leadership and his experience align perfectly with our corporate development efforts and strategic growth initiatives." Read More

See more Faron Pharmaceuticals news
FTSE 100 Latest
Value9,177.24
Change0.00

Login to your account

Forgot Password?

Not Registered